I-02 Gauri Rao A Proposed Adaptive Feedback Control (AFC) Algorithm for Linezolid (L) based on Population Pharmacokinetics (PK)/Pharmacodynamics (PD)/Toxicodynamics(TD) Wednesday 10:05-11:40 |
I-12 Alessandro Schipani Population pharmacokinetic of rifampicine in Malawian children. Wednesday 10:05-11:40 |
I-33 Joel Tarning The population pharmacokinetic and pharmacodynamic properties of intramuscular artesunate and quinine in Tanzanian children with severe falciparum malaria; implications for a practical dosing regimen. Wednesday 10:05-11:40 |
I-40 Elodie Valade Population Pharmacokinetics of Emtricitabine in HIV-1-infected Patients Wednesday 10:05-11:40 |
II-01 Thomas Dorlo Miltefosine treatment failure in visceral leishmaniasis in Nepal is associated with low drug exposure Wednesday 14:50-16:20 |
II-17 Ronette Gehring A dynamically integrative PKPD model to predict the efficacy of marbofloxacin treatment regimens for bovine Mannheimia hemolytica infection Wednesday 14:50-16:20 |
II-34 Monia Guidi Impacts of environmental, clinical and genetic factors on the response to vitamin D supplementation in HIV-positive patients Wednesday 14:50-16:20 |
II-48 Nerea Jauregizar Pharmacokinetic/Pharmacodynamic modeling of time-kill curves for echinocandins against Candida. Wednesday 14:50-16:20 |
II-50 Sangil Jeon Population Pharmacokinetics of Piperacillin in Burn Patients Wednesday 14:50-16:20 |
II-58 Takayuki Katsube Pharmacokinetic/pharmacodynamic modeling and simulation for concentration-dependent bactericidal activity of a bicyclolide, modithromycin Wednesday 14:50-16:20 |
II-59 Irene-Ariadne Kechagia Population pharmacokinetic analysis of colistin after administration of inhaled colistin methanesulfonate. Wednesday 14:50-16:20 |
II-61 Frank Kloprogge Population pharmacokinetics and pharmacodynamics of lumefantrine in pregnant women with uncomplicated P. falciparum malaria. Wednesday 14:50-16:20 |
III-20 Jesmin Lohy Das Simulations to investigate new Intermittent Preventive Therapy Dosing Regimens for Dihydroartemisinin-Piperaquine Thursday 10:05-11:35 |
III-37 Iris Minichmayr A Microdialysate-based Integrated Model with Nonlinear Elimination for Determining Plasma and Tissue Pharmacokinetics of Linezolid in Four Distinct Populations Thursday 10:05-11:35 |
IV-04 Sarah Alghanem Comparison of NONMEM and Pmetrics Analysis for Aminoglycosides in Adult Patients with Cystic Fibrosis Thursday 14:55-16:20 |
IV-11 Eduardo Asín-Prieto Population Pharmacokinetics of Cefuroxime in patients Undergoing Colorectal Surgery Thursday 14:55-16:20 |
IV-27 Margreke Brill Population pharmacokinetic model for protein binding and subcutaneous adipose tissue distribution of cefazolin in morbidly obese and non-obese patients Thursday 14:55-16:20 |
IV-48 Oskar Clewe A Model Predicting Penetration of Rifampicin from Plasma to Epithelial Lining Fluid and Alveolar Cells Thursday 14:55-16:20 |
IV-52 Camille Couffignal Population pharmacokinetics of imipenem in intensive care unit patients with ventilated-associated pneumonia Thursday 14:55-16:20 |